https://www.academia.edu/143847770/Phase_I_Study_of_Entinostat_Atezolizumab_Carboplatin_and_Etoposide_in_Previously_Untreated_Extensive_Stage_Small_Cell_Lung_Cancer_ETCTN_10399
Background CREBBP and EP300 mutations occur at a frequency of 15% and 13%, respectively, in small cell lung cancer (SCLC), and preclinical models demonstrated...
phase i studypdfentinostatatezolizumabcarboplatin